Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Parkinson Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableUnknownNCT05273957
What this trial is testing

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.

Who this might be right for
Parkinson DiseaseAtypical ParkinsonismSecondary Parkinsonism+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05669170
What this trial is testing

Methylphenidate for Apathy in Veterans With Parkinson's Disease

Who this might be right for
Parkinson DiseaseApathy
Ralph H. Johnson VA Medical Center 60
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT06671938
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Who this might be right for
Parkinson DiseaseMultiple System Atrophy
BioArctic AB 38
Post-approval studies (Phase 4)Study completedNCT01168596
What this trial is testing

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Florida 30
Not applicableUnknownNCT04589182
What this trial is testing

Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease

Who this might be right for
Parkinson DiseaseMild Cognitive ImpairmentHuntington Disease
Christian Baumann 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775096
What this trial is testing

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Michele Tagliati, MD 15
Testing effectiveness (Phase 2)Study completedNCT01341431
What this trial is testing

Bee Venom for the Treatment of Parkinson Disease

Who this might be right for
Parkinson Disease
Assistance Publique - Hôpitaux de Paris 50
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Testing effectiveness (Phase 2)Study completedNCT02111122
What this trial is testing

Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

Who this might be right for
Sleep-wake Disturbances in Motor-phase Parkinson's Disease
Christian Baumann 16
Not applicableStudy completedNCT03432338
What this trial is testing

Distribution of Non-Motor Symptoms in Idiopathic Parkinson's Disease and Secondary Parkinsonism

Who this might be right for
Parkinson Disease
Örjan Skogar 208
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386317
What this trial is testing

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson's DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Not applicableStudy completedNCT05480215
What this trial is testing

Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands

Who this might be right for
Essential TremorParkinson Disease
Cala Health, Inc. 20
Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Not applicableUnknownNCT02275884
What this trial is testing

Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Technische Universität Dresden 30
Post-approval studies (Phase 4)Study completedNCT02586623
What this trial is testing

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
H. Lundbeck A/S 453
Load More Results